185 related articles for article (PubMed ID: 16964563)
1. Vasoactive intestinal polypeptide suppressed experimental autoimmune encephalomyelitis by inhibiting T helper 1 responses.
Li H; Mei Y; Wang Y; Xu L
J Clin Immunol; 2006 Sep; 26(5):430-7. PubMed ID: 16964563
[TBL] [Abstract][Full Text] [Related]
2. Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells.
Kato H; Ito A; Kawanokuchi J; Jin S; Mizuno T; Ojika K; Ueda R; Suzumura A
Mult Scler; 2004 Dec; 10(6):651-9. PubMed ID: 15584490
[TBL] [Abstract][Full Text] [Related]
3. 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis.
Nath N; Giri S; Prasad R; Salem ML; Singh AK; Singh I
J Immunol; 2005 Jul; 175(1):566-74. PubMed ID: 15972693
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis.
Chen SJ; Wang YL; Lo WT; Wu CC; Hsieh CW; Huang CF; Lan YH; Wang CC; Chang DM; Sytwu HK
Clin Exp Immunol; 2010 Nov; 162(2):210-23. PubMed ID: 21069936
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo.
Bedoui S; Miyake S; Lin Y; Miyamoto K; Oki S; Kawamura N; Beck-Sickinger A; von Hörsten S; Yamamura T
J Immunol; 2003 Oct; 171(7):3451-8. PubMed ID: 14500640
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis: down-regulation of inflammatory and autoimmune responses.
Gonzalez-Rey E; Fernandez-Martin A; Chorny A; Martin J; Pozo D; Ganea D; Delgado M
Am J Pathol; 2006 Apr; 168(4):1179-88. PubMed ID: 16565493
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic effect of vasoactive intestinal peptide on experimental arthritis is associated with CD4+CD25+ T regulatory cells.
Chen G; Hao J; Xi Y; Wang W; Wang Z; Li N; Li W
Scand J Immunol; 2008 Dec; 68(6):572-8. PubMed ID: 19055696
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive effect of silibinin in experimental autoimmune encephalomyelitis.
Min K; Yoon WK; Kim SK; Kim BH
Arch Pharm Res; 2007 Oct; 30(10):1265-72. PubMed ID: 18038905
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response.
Matsushita T; Fujimoto M; Hasegawa M; Komura K; Takehara K; Tedder TF; Sato S
Am J Pathol; 2006 Mar; 168(3):812-21. PubMed ID: 16507897
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
[TBL] [Abstract][Full Text] [Related]
11. The heat shock response reduces myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in mice.
Heneka MT; Sharp A; Murphy P; Lyons JA; Dumitrescu L; Feinstein DL
J Neurochem; 2001 Apr; 77(2):568-79. PubMed ID: 11299319
[TBL] [Abstract][Full Text] [Related]
12. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
[TBL] [Abstract][Full Text] [Related]
13. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses.
Nizri E; Irony-Tur-Sinai M; Lory O; Orr-Urtreger A; Lavi E; Brenner T
J Immunol; 2009 Nov; 183(10):6681-8. PubMed ID: 19846875
[TBL] [Abstract][Full Text] [Related]
14. Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
Yun J; Gu SM; Yun HM; Son DJ; Park MH; Lee MS; Hong JT
Oncotarget; 2015 Dec; 6(38):40452-63. PubMed ID: 26564962
[TBL] [Abstract][Full Text] [Related]
15. Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE).
Yura M; Takahashi I; Serada M; Koshio T; Nakagami K; Yuki Y; Kiyono H
J Autoimmun; 2001 Aug; 17(1):17-25. PubMed ID: 11488634
[TBL] [Abstract][Full Text] [Related]
16. Induction of experimental autoimmune encephalomyelitis in the absence of c-Jun N-terminal kinase 2.
Nicolson K; Freland S; Weir C; Delahunt B; Flavell RA; Bäckström BT
Int Immunol; 2002 Aug; 14(8):849-56. PubMed ID: 12147621
[TBL] [Abstract][Full Text] [Related]
17. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
18. The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents.
Dinter H; Tse J; Halks-Miller M; Asarnow D; Onuffer J; Faulds D; Mitrovic B; Kirsch G; Laurent H; Esperling P; Seidelmann D; Ottow E; Schneider H; Tuohy VK; Wachtel H; Perez HD
J Neuroimmunol; 2000 Aug; 108(1-2):136-46. PubMed ID: 10900347
[TBL] [Abstract][Full Text] [Related]
19. 17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis.
Matejuk A; Adlard K; Zamora A; Silverman M; Vandenbark AA; Offner H
J Neurosci Res; 2001 Sep; 65(6):529-42. PubMed ID: 11550221
[TBL] [Abstract][Full Text] [Related]
20. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
